Skip Ribbon Commands
Skip to main content

W. Nicholson Price II

W. Nicholson Price II

Assistant Professor of Law
Member of University of Michigan Law School Faculty 2016-


Publications

Forthcoming | Books | Book ChaptersJournal Articles | Reviews
Other Publications | Reprints | Works in Progress & Working Papers


Forthcoming

  • "Medical Malpractice and Black-Box Medicine." In The Cambridge Handbook of Big Data, Health Law, and Bioethics, edited by E. et al. Vayena. Cambridge University Press, Forthcoming, 2018.
  • "Risk and Resilience in Health Data Infrastructure." Colo. Sci. &Tech. R. (Forthcoming).
    Full Text: MLaw Repository | SSRN
  • "Regulating Black-Box Medicine." Mich. L. Rev (Forthcoming).

Book Chapters

  • "Innovation Policy Failures in the Manufacturing of Drugs." In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies, edited by H.F.Lynch and I.G.Cohen, 343-58. Columbia University Press, 2015. (Work published when author not on Michigan Law faculty.)
    MLaw Catalog

Journal Articles

  • "Expired Patients, Trade Secrets, and Stymied Competition." Notre Dame L. Rev. 92, no. 4 (2017): 1611-40.
    Full Text: HEIN (UMich users) | HEIN | WWW
  • Co-author. "Demand-Side Innovation in Health Care." Eisenberg, Rebecca S. (1984- ), co-author. J. L. & Biosciences 4, no. 1 (2017): 3-49.
    Full Text: Oxford (UMich users) | Oxford
  • "Regulating Secrecy." Wash. L. Rev. 91, no. 4 (2016): 1769-812.
    Full Text: HEIN (UMich users) | HEIN
  • Co-author. "Privacy and Accountability in Black-Box Medicine." R.Ford, co-author. Mich. Telecomm. & Tech. L. Rev. 23, no. 1 (2016): 1-43.
    Full Text: MLaw Repository | HEIN (UMich users) | HEIN
  • Co-author. "The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases." D. Klonoff, co-author. J. Diabetes Sci. & Tech. 11, no. 2 (2016): 220-3.
    Full Text: WWW
  • Co-author. "Manufacturing Barriers to Biologics Competition and Innovation." A. Rai, co-author. Iowa L. Rev. 101, no. 3 (2016): 1023-63.
    Full Text: MLaw Repository | LegalTrac (UMich users) | LegalTrac | HEIN (UMich users) | HEIN | SSRN
  • "Big Data, Patents, and the Future of Medicine." Cardozo L. Rev. 37, no. 4 (2016): 1401-53.
    Full Text: WWW | SSRN
  • Co-author. "Codon Influence on Large-Scale Protein Expression Correlates with E.Coli mRNA Levels." G.Boel et al., co-authors. Nature 529, no. 7586 (2016): 358-63.
    Full Text: WWW
  • Co-author. "Will clinical trial data disclosure reduce incentives to develop new uses of drugs?" T.Minssen, co-author. Nature Biotech. 33, no. 7 (2015): 685-6. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Describing Black-Box Medicine." Boston U. J. Sci & Tech. L. 21, no. 2 (2015): 347-56. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | SSRN
  • "Black-Box Medicine." Harv. J. L. & Tech. 28, no. 2 (2015): 419-67. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | SSRN
  • Co-author. "Are trade secrets delaying biosimilars?" A. Rai, co-author. Science 348, no. 6231 (April 10, 2015): 188-9. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • Co-author. "Patent Trolling - Why Bio & Pharmaceuticals Are at Risk." R.Feldman, co-author. Stan. Tech. L. Rev. 17, no. 2 (2014): 773-809. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | SSRN
  • Co-author. "Nudging the FDA." I.G.Cohen, co-author. Am. Interest 10, no. 2 (2014): 35. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • Co-author. "Models of Consent to Return of Incidental Findings in Genomic Research." P. S. Appelbaum et al., co-authors. Hastings Center Rep. 44, no. 4 (2014): 22-32. (Work published when author not on Michigan Law faculty.
    Full Text: Wiley (UMich users) | Wiley
  • "Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing." B. C. L. Rev. 55, no. 2 (2014): 491-562. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | SSRN
  • "Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing." Intell. Prop. Theory 4, no. 1 (2014): 1-8. (Work published when author not on Michigan Law faculty.)
    Full Text: SSRN
  • "Problems of Innovation-Deficient Pharmaceutical Manufacturing." New Engl. J. Med. (2013): 1-3. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • Co-author. "Informed Consent for Return of Incidental Findings in Genomic Research." P. S. Appelbaum et al., co-authors. Genetics in Med. 16, no. 5 (2013): 367-73. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Large-Scale Experimenta Studies Show Unexpected Amino Acid Effects on Protein Expression and Solubility in Vivo in E. Coli." S. K. Handelman et al., co-authors. Microbial Informatics and Experimentation 6, no. 1 (2011): 1-6. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Am I My Son? Human Clones and the Modern Family." Colum. Sci. &Tech. L. Rev. 11 (2010): 119-51. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users)| HEIN | SSRN
  • Co-author. "Understanding the Pysical Properties that Control Protein Crystiallization by Analysis of Large-Sale Experimental Data." Yang Chen et al., co-authors. Nature Biotech. 27, no. 1 (2009): 51-7. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • Co-author. "MxA Gene Expression Anaylsis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity." A. Pacner et al., co-authors. Molecular Diagnosis 7, no. 1 (2003): 17-23. (Work published when author not on Michigan Law faculty.)
    Full Text: Springer (UMich user) | Springer

Other Publications

  • Introduction to "Timing is Everything". In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies, edited by H.F.Lynch and I.G.Cohen, 247-50. Columbia University Press, 2015. (Work published when author not on Michigan Law faculty.)
    Full Text: DeGruyter (UMich users) | DeGruyter
Forthcoming | Books | Book Chapters | Journal Articles | Reviews
Other Publications | Reprints | Works in Progress & Working Papers

Revised 10/11/2017